Answer:
Details about DNA are given in the explanation section. Hope it will be helpful for you.
Explanation:
DNA, or deoxyribonucleic acid, is the hereditary element in humans and almost all other organisms. Nearly every cell in a person’s body has the same type of DNA. Most DNA is found in the cell nucleus (nuclear DNA), but a small quantity of DNA can also be found in the mitochondria (mitochondrial DNA or mtDNA).
The information in DNA is stored as a code made up of four chemical bases: adenine (A), guanine (G), cytosine (C), and thymine (T). Human DNA consists of about 3 billion bases, and more than 99 percent of those bases are the same type in all people.
DNA bases pair up with each other, A with T and C with G, to form units that are called base pairs. Each base is also attached to a sugar molecule and a phosphate molecule. A base, sugar, and phosphate are called a nucleotide. Nucleotides are arranged in two long strands that form a spiral called a double helix.
A valuable feature of DNA is that it can replicate, or make copies of itself. Each strand of DNA in the double helix can serve as a pattern for duplicating the sequence of bases.
Barack Obama was elected president in November of 2008. He was sworn in January 20, 2009.
Answer:
I think that the beak of the finches will evolve over time depending on what kinds of food they eat. I made this hypothesis by reaching other birds of that nature.
Explanation:
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
